Stay updated on Pembrolizumab for Cancer of Unknown Primary Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Cancer of Unknown Primary Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Cancer of Unknown Primary Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new site revision v3.5.4 was added, replacing the previous revision v3.5.3. This reflects a routine platform update without changes to study information.
    Difference
    0.1%
    Check dated 2026-05-15T15:28:46.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Adds a Results and Publications section with post-study outcomes and citations for the CUPem trial, including major publications; also removes earlier narrative summaries of efficacy and RECIST-based outcomes.
    Difference
    6%
    Check dated 2026-05-08T12:11:21.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page’s footer “Revision” label has been updated from v3.5.2 to v3.5.3, indicating a minor site/content system revision rather than a change to the clinical trial details.
    Difference
    0.1%
    Check dated 2026-04-24T05:51:47.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:09:27.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and Revision: v3.4.3 removed from the page. This update does not change study details, eligibility criteria, or other user-facing content.
    Difference
    0.1%
    Check dated 2026-03-18T21:54:15.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.3. The previous revision label v3.4.2 has been removed.
    Difference
    0.1%
    Check dated 2026-03-11T17:15:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Cancer of Unknown Primary Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Cancer of Unknown Primary Clinical Trial page.